Literature DB >> 27344293

Circulating Tumor Cell Count as an Indicator of Treatment Benefit in Advanced Prostate Cancer.

David Neal1, Hans Lilja2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27344293     DOI: 10.1016/j.eururo.2016.06.014

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  2 in total

Review 1.  Effect of high-intensity interval training on aerobic capacity and fatigue among patients with prostate cancer: a meta-analysis.

Authors:  Ming Chang; Junguo Wang; Hairul A Hashim; Shihao Xie; Adam A Malik
Journal:  World J Surg Oncol       Date:  2022-10-19       Impact factor: 3.253

2.  Molecular analysis of single circulating tumour cells following long-term storage of clinical samples.

Authors:  Barbara Mesquita; Dominic G Rothwell; Deborah J Burt; Francesca Chemi; Fabiola Fernandez-Gutierrez; Daniel Slane-Tan; Jenny Antonello; Mathew Carter; Louise Carter; Marina Parry; Lynsey Franklin; Richard Marais; Fiona Blackhall; Caroline Dive; Ged Brady
Journal:  Mol Oncol       Date:  2017-10-24       Impact factor: 6.603

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.